Bayer completes $1.1bn Conceptus buy
This article was originally published in Scrip
Executive Summary
Bayer has completed its $1.1bn acquisition of Conceptus, a US firm that developed and markets the Essure birth control method. The deal was announced last month (scripintelligence.com, 9 May 2013).